What does DR. BORKELMANS do?

DR. BORKELMANS is a general practice in Maasmechelen. Private Limited, started on 28 February 2012.

What is the address of DR. BORKELMANS?

The registered office of DR. BORKELMANS is located at Putstraat(M) 49, 3630 Maasmechelen.

Is DR. BORKELMANS still active?

Yes. According to the CBE (30 September 2026) DR. BORKELMANS is active, legal situation “Normale toestand”, started on 28 February 2012.

Is DR. BORKELMANS registered on Peppol?

Yes, DR. BORKELMANS is registered on the Peppol network with ID 0208:0844079548.

What is the enterprise number of DR. BORKELMANS?

The enterprise number of DR. BORKELMANS is BE0844079548.

When was DR. BORKELMANS founded?

DR. BORKELMANS was founded on 28 February 2012.

Who are the directors of DR. BORKELMANS?

According to the 2025 annual accounts, the directors of DR. BORKELMANS are: Hilde Martha P Borkelmans.

Is DR. BORKELMANS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 February 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. BORKELMANS make in 2025?

DR. BORKELMANS posted a profit after taxes of € 49,253 in financial year 2025.

What is the revenue of DR. BORKELMANS?

As a small company, DR. BORKELMANS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 119,844.

DR. BORKELMANS (Private Limited) - Maasmechelen

Dossier DR. BORKELMANS, printed on 30 September 2026 from databakkes.be/en/0844079548/dr-borkelmans. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. BORKELMANS from Maasmechelen, company number BE0844079548, closed financial year 2025 with a result of € 49,253 after tax. For that financial year DR. BORKELMANS recorded a gross margin of € 119,844 and equity of € 257,271. Compared with financial year 2024, the result moved from € 36,165 to € 49,253. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Growing

€ 257,271

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 49,253

▲ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 152,078

▲ 47% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 27,721 paid out

56 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 763

▼ 96% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 139

▼ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 265

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 130,295 Gross margin 2022: € 130,295 First fiscal year in the series	€ 113,061 Gross margin 2023: € 113,061 ▼ 13% vs 2022 (€ 130,295) Unfavourable step	€ 109,056 Gross margin 2024: € 109,056 ▼ 4% vs 2023 (€ 113,061) Unfavourable step	€ 119,844 Gross margin 2025: € 119,844 ▲ 10% vs 2024 (€ 109,056) Favourable step	▲ 10%
Profit after taxes	€ 40,504 Profit after taxes 2022: € 40,504 First fiscal year in the series	€ 34,118 Profit after taxes 2023: € 34,118 ▼ 16% vs 2022 (€ 40,504) Unfavourable step	€ 36,165 Profit after taxes 2024: € 36,165 ▲ 6% vs 2023 (€ 34,118) Favourable step	€ 49,253 Profit after taxes 2025: € 49,253 ▲ 36% vs 2024 (€ 36,165) Favourable step	▲ 36%
Equity	€ 213,487 Equity 2022: € 213,487 First fiscal year in the series	€ 247,605 Equity 2023: € 247,605 ▲ 16% vs 2022 (€ 213,487) Favourable step	€ 235,739 Equity 2024: € 235,739 ▼ 5% vs 2023 (€ 247,605) Unfavourable step	€ 257,271 Equity 2025: € 257,271 ▲ 9% vs 2024 (€ 235,739) Favourable step	▲ 9%
Total debts	€ 196,975 Total debts 2022: € 196,975 First fiscal year in the series	€ 6,925 Total debts 2023: € 6,925 ▼ 96% vs 2022 (€ 196,975) Favourable step	€ 18,537 Total debts 2024: € 18,537 ▲ 168% vs 2023 (€ 6,925) Unfavourable step	€ 4,884 Total debts 2025: € 4,884 ▼ 74% vs 2024 (€ 18,537) Favourable step	▼ 74%
Cash	€ 146,903 Cash 2022: € 146,903 First fiscal year in the series	€ 55,110 Cash 2023: € 55,110 ▼ 62% vs 2022 (€ 146,903) Unfavourable step	€ 103,747 Cash 2024: € 103,747 ▲ 88% vs 2023 (€ 55,110) Favourable step	€ 152,078 Cash 2025: € 152,078 ▲ 47% vs 2024 (€ 103,747) Favourable step	▲ 47%
Retained profit	€ 201,087 Retained profit 2022: € 201,087 First fiscal year in the series	€ 235,205 Retained profit 2023: € 235,205 ▲ 17% vs 2022 (€ 201,087) Favourable step	€ 223,339 Retained profit 2024: € 223,339 ▼ 5% vs 2023 (€ 235,205) Unfavourable step	€ 244,871 Retained profit 2025: € 244,871 ▲ 10% vs 2024 (€ 223,339) Favourable step	▲ 10%
Dividend	€ 185,349 Dividend 2022: € 185,349 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 185,349) Unchanged	€ 48,031 Dividend 2024: € 48,031 Unchanged (€ 0) Unchanged	€ 27,721 Dividend 2025: € 27,721 ▼ 42% vs 2024 (€ 48,031) Unchanged	▼ 42%
Balance sheet total	€ 410,462 Balance sheet total 2022: € 410,462 First fiscal year in the series	€ 254,530 Balance sheet total 2023: € 254,530 ▼ 38% vs 2022 (€ 410,462) Unchanged	€ 254,276 Balance sheet total 2024: € 254,276 Unchanged (€ 254,530) Unchanged	€ 262,155 Balance sheet total 2025: € 262,155 ▲ 3% vs 2024 (€ 254,276) Unchanged	▲ 3%

Key figures of DR. BORKELMANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. BORKELMANS?

What happened at DR. BORKELMANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 49,253 (▲ 36% vs 2024). Source: NBB ↗
Feb 28, 2012 Start of the company according to the CBE. KBO

In short

From € 40,504 profit in 2022 to € 49,253 profit in 2025.

Paid € 66,809 in corporate taxes since 2022.

Best year ever: 2025, with € 49,253 profit.

Paid out € 261,101 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. BORKELMANS? We notify you, reason included.

Follow DR. BORKELMANS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Hilde Martha P Borkelmans

DR. BORKELMANS

Behind DR. BORKELMANS is Hilde Martha P Borkelmans.

See the full network in the app

Directors

According to the 2025 annual accounts

Hilde Martha P Borkelmans

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Putstraat(M) 49

3630 Maasmechelen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0844.079.548
VAT number: BE 0844.079.548
Registered office: Putstraat(M) 49, 3630 Maasmechelen
Names & denominations: DR. BORKELMANS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 February 2012
Peppol: Active · Active since 5 Oct 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗